
Triprand 2mg/500mg/0.2mg Tablet
Marketer
Inviscus Lifescience LLP
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Triprand 2mg/500mg/0.2mg Tablet
Diabetam 2mg/500mg/0.2mg tablets are classified as antidiabetic medications, a combination therapy for adult type 2 diabetes. This medication helps regulate blood glucose in diabetic patients. Diabetam 2mg/500mg/0.2mg tablets should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continue taking this medication even with well-controlled blood sugar; abrupt cessation, without physician consultation, risks elevated blood glucose and potential complications including kidney impairment, vision loss, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan, including diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. The most frequent adverse reaction to Diabetam 2mg/500mg/0.2mg is hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms (sweating, dizziness, headache, tremors) and appropriate management. Maintain regular mealtimes and always carry a readily available glucose source, like sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your physician prior to commencing treatment. Pregnant or breastfeeding individuals should consult their doctor before use. Regular blood glucose monitoring is essential; your doctor may also recommend blood tests to monitor blood cell counts and liver function.
Uses of Triprand 2mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Triprand 2mg/500mg/0.2mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the Triprand 2mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
Common Side effects of Triprand 2mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Triprand 2mg/500mg/0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Triprand 2mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or fracturing. Administer on an empty stomach.
How Triprand 2mg/500mg/0.2mg Tablet works:
Each Triprand tablet (2mg/500mg/0.2mg) contains a blend of three antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Triprand 2mg/500mg/0.2mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Triprand 2mg/500mg/0.2mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Triprand 2mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Triprand 2mg/500mg/0.2mg tablets pose a likely safety risk for individuals with kidney impairment and should be omitted. Seek medical advice before use. The use of Triprand 2mg/500mg/0.2mg tablets is contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Triprand 2mg/500mg/0.2mg tablets cautiously, potentially requiring dose modification. A physician's consultation is advised. For individuals with mild to moderate liver disease, initiation should be at a low dosage; however, its use is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Triprand 2mg/500mg/0.2mg Tablet :
Should you forget to take your Triprand 2mg/500mg/0.2mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Triprand 2mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Treatment |
